Biontech   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Mainz Germany (2008)

Organization Overview

First Clinical Trial
2012
NCT01684241
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Biontech AG | BioNTech Cell & Gene Therapies GmbH | Biontech RNA Pharmaceuticals GmbH | BioNTech RNA Pharmaceuticals GmbH | Biontech SE | BioNTech SE | BioNTech Small Molecules GmbH | BioNTech US Inc.